EMEREN GROUP LTD (SOL) Fundamental Analysis & Valuation

NYSE:SOL • US75971T3014

Current stock price

1.94 USD
+0.01 (+0.52%)
At close:
1.94 USD
0 (0%)
After Hours:

This SOL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SOL Profitability Analysis

1.1 Basic Checks

  • SOL had negative earnings in the past year.
  • SOL had a positive operating cash flow in the past year.
  • In multiple years SOL reported negative net income over the last 5 years.
  • SOL had a negative operating cash flow in each of the past 5 years.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • SOL has a Return On Assets of -2.03%. This is in the lower half of the industry: SOL underperforms 72.73% of its industry peers.
  • With a Return On Equity value of -2.94%, SOL is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.03%
ROE -2.94%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • The Gross Margin of SOL (33.95%) is better than 85.45% of its industry peers.
  • In the last couple of years the Gross Margin of SOL has declined.
  • The Profit Margin and Operating Margin are not available for SOL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. SOL Health Analysis

2.1 Basic Checks

  • SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SOL has less shares outstanding
  • Compared to 5 years ago, SOL has more shares outstanding
  • SOL has a worse debt/assets ratio than last year.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • SOL has an Altman-Z score of -0.51. This is a bad value and indicates that SOL is not financially healthy and even has some risk of bankruptcy.
  • SOL's Altman-Z score of -0.51 is on the low side compared to the rest of the industry. SOL is outperformed by 89.09% of its industry peers.
  • The Debt to FCF ratio of SOL is 2.04, which is a good value as it means it would take SOL, 2.04 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SOL (2.04) is better than 76.36% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that SOL is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.20, SOL is doing good in the industry, outperforming 76.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.04
Altman-Z -0.51
ROIC/WACCN/A
WACC9.96%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 4.28 indicates that SOL has no problem at all paying its short term obligations.
  • SOL has a better Current ratio (4.28) than 98.18% of its industry peers.
  • SOL has a Quick Ratio of 4.28. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
  • SOL's Quick ratio of 4.28 is amongst the best of the industry. SOL outperforms 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.28
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SOL Growth Analysis

3.1 Past

  • SOL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.67%.
  • The Revenue for SOL has decreased by -30.50% in the past year. This is quite bad
  • SOL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.02% yearly.
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.15%
Revenue 1Y (TTM)-30.5%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%21.63%

3.2 Future

  • SOL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.80% yearly.
  • Based on estimates for the next years, SOL will show a quite strong growth in Revenue. The Revenue will grow by 11.79% on average per year.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. SOL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SOL. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 9.37, the valuation of SOL can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SOL indicates a rather cheap valuation: SOL is cheaper than 98.18% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of SOL to the average of the S&P500 Index (22.19), we can say SOL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.37
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • 70.91% of the companies in the same industry are cheaper than SOL, based on the Enterprise Value to EBITDA ratio.
  • 100.00% of the companies in the same industry are more expensive than SOL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 304.9
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • SOL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SOL's earnings are expected to grow with 72.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SOL Dividend Analysis

5.1 Amount

  • No dividends for SOL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOL Fundamentals: All Metrics, Ratios and Statistics

EMEREN GROUP LTD

NYSE:SOL (12/12/2025, 8:04:00 PM)

After market: 1.94 0 (0%)

1.94

+0.01 (+0.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-12
Earnings (Next)03-11
Inst Owners43.09%
Inst Owner Change-99.64%
Ins Owners1.06%
Ins Owner Change0%
Market Cap99.56M
Revenue(TTM)71.23M
Net Income(TTM)-9.13M
Analysts80
Price Target7.14 (268.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33.08%
Min Revenue beat(2)-34.82%
Max Revenue beat(2)-31.34%
Revenue beat(4)0
Avg Revenue beat(4)-30.41%
Min Revenue beat(4)-40.72%
Max Revenue beat(4)-14.76%
Revenue beat(8)2
Avg Revenue beat(8)-16.88%
Revenue beat(12)2
Avg Revenue beat(12)-26.69%
Revenue beat(16)3
Avg Revenue beat(16)-26.82%
PT rev (1m)0%
PT rev (3m)55.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.37
P/S 1.4
P/FCF 2.96
P/OCF 2.22
P/B 0.32
P/tB 0.32
EV/EBITDA 304.9
EPS(TTM)-0.21
EYN/A
EPS(NY)0.21
Fwd EY10.67%
FCF(TTM)0.66
FCFY33.81%
OCF(TTM)0.87
OCFY44.98%
SpS1.39
BVpS6.05
TBVpS6.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.03%
ROE -2.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.95%
FCFM 47.26%
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.04
Debt/EBITDA 222.61
Cap/Depr 131.99%
Cap/Sales 15.62%
Interest Coverage N/A
Cash Conversion 16346%
Profit Quality N/A
Current Ratio 4.28
Quick Ratio 4.28
Altman-Z -0.51
F-Score3
WACC9.96%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.15%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.5%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%21.63%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-598.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y181.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y208.42%
OCF growth 3YN/A
OCF growth 5YN/A

EMEREN GROUP LTD / SOL Fundamental Analysis FAQ

What is the fundamental rating for SOL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SOL.


What is the valuation status of EMEREN GROUP LTD (SOL) stock?

ChartMill assigns a valuation rating of 6 / 10 to EMEREN GROUP LTD (SOL). This can be considered as Fairly Valued.


What is the profitability of SOL stock?

EMEREN GROUP LTD (SOL) has a profitability rating of 1 / 10.


How financially healthy is EMEREN GROUP LTD?

The financial health rating of EMEREN GROUP LTD (SOL) is 6 / 10.